Volume 12 (2014): Issue 5S (May 2014): Highlights from the NCCN 19th Annual Conference

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
Advancing the Standard of Cancer Care in 2014
By: Robert W. Carlson
Pages: 743–744
The Affordable Care Act: Where Are We Now? An NCCN Roundtable
By: Christian G. Downs, Liz Fowler, Michael Kolodziej, Lee H. Newcomer, Mohammed S. Ogaily, W. Thomas Purcell, John C. Winkelmann, and Clifford Goodman
Pages: 745–747
Genomic Analysis of Breast Cancer Heralds a Changing Treatment Paradigm
By: Matthew Ellis
Pages: 750–752
Treatment of Metastatic Breast Cancer
By: William J. Gradishar
Pages: 759–761
Advances in the Treatment of Non-Small Cell Lung Cancer
By: Leora Horn
Pages: 764–767
Point/Counterpoint: Early Detection of Prostate Cancer: Do the Benefits Outweigh the Consequences?
By: Peter R. Carroll and Andrew J. Vickers
Pages: 768–771
New Developments in the Treatment of Castration-Resistant Prostate Cancer
By: Celestia S. Higano
Pages: 773–776
NCCN Roundtable: Talking to Children About Cancer
By: Martha Aschenbrenner, Bruce Ham, Paula K. Rauch, Zoraida Sambolin, Maya Silver, and Lillie D. Shockney
Pages: 777–779
Optimizing Surveillance and Balancing Evidence With Patient Expectations
By: Crystal Denlinger and Terry S. Langbaum
Pages: 781–784
Agents Make “Preferred List” in Metastatic Melanoma
By: John A. Thompson
Pages: 785–787
Optimal Treatment of Unresectable Nonmelanoma Skin Cancers
By: Thomas Olencki
Pages: 789–792
Targeted Agents: Management of Dermatologic Toxicities
By: Barbara Burtness
Pages: 793–796
Guidelines for NHL: Updates to the Management of Diffuse Large B-Cell Lymphoma and New Guidelines for Primary Cutaneous CD30+ T-Cell Lymphoproliferative Disorders and T-Cell Large Granular Lymphocytic Leukemia
By: Andrew D. Zelenetz
Pages: 797–800
Chronic Lymphocytic Leukemia: State of the Art and Beyond
By: John C. Byrd
Pages: 801–803
Multiple Myeloma: Advances Reported in 2013 Are Useful in the Clinic
By: Kenneth Anderson
Pages: 808–811
NCCN Bone Health Task Force: Key Recommendations
By: Azeez Farooki
Pages: 813–816
Monitoring Molecular Response to Tyrosine Kinase Therapy in Chronic Myelogenous Leukemia
By: Jerald P. Radich
Pages: 817–820
Treatment Strategies for Myeloid Growth Factors and Intravenous Iron: When, What, and How?
By: Jeffrey Crawford and George M. Rodgers
Pages: 821–824
NCCN Guidelines for Survivorship Expanded to Address Two Common Conditions
By: Elizabeth Kvale and Susan G. Urba
Pages: 825–827
NCCN Increases the Emphasis on Genetic/Familial High-Risk Assessment in Colorectal Cancer
By: Heather Hampel
Pages: 829–831
Common Controversies in the Management of Gallbladder Cancer
By: Chandrakanth Are
Pages: 833–835
Don’t Neglect Cultural Diversity in Oncology Care
By: Teresita Muñoz-Antonia
Pages: 836–837
International Adaptation and Use of NCCN Guidelines
By: Ali Bazarbachi and Andrew D. Zelenetz
Pages: 838–841
  • Collapse
  • Expand